Design Therapeutics, Inc. DSGN Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s total current liabilities?
- Design Therapeutics, Inc. (DSGN) reported total current liabilities of $10.19M in Q1 2026.
- How has Design Therapeutics, Inc.'s total current liabilities changed year-over-year?
- Design Therapeutics, Inc.'s total current liabilities increased by 23.7% year-over-year, from $8.24M to $10.19M.
- What is the long-term trend for Design Therapeutics, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s total current liabilities has grown at a 41.2% compound annual growth rate (CAGR), from $2.33M to $13.06M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.